Wire · regulatory
Trump expected to nominate Heidi Overton as FDA commissioner
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 19 August 2026 · Fusion42 review
President Donald Trump is expected to nominate Dr. Heidi Overton, a White House policy aide with a conservative health policy background, as the next FDA commissioner, replacing Marty Makary. Overton's nomination signals potential shifts in FDA policies around drug regulation, tobacco products, and chemical oversight under the Trump administration's influence.
This Wire brief sits within Fusion42's coverage of Health, and 12 sources have reported it between 19 Aug 2026 and 20 Aug 2026.
◆ ◆ The Wire takeaway
You must prepare for stricter controls on drug and tobacco regulation since the FDA's new leader has a conservative policy background and controversial views on abortion and drug oversight. Your regulatory strategy in pharmaceuticals and health-related sectors will face new scrutiny under her leadership.
◆ Coverage
12 sources · first reported 19 Aug 2026 · latest 20 Aug 2026
◆ Related on Wire
◆ Topics